Robert A Stull

This inventor holds 44 USPTO granted patents and 15 published patent applications, plus 3 CIPO patents and 5 EPO patents, primarily in Antibody Drug Conjugates. Top assignees: Abbvie Stemcentrx LLC, Stemcentrx, Inc., University of California. Active years: 2001-2021.

USPTO Granted Patents = 44 (Patent Applications = 15)

% Patents Active = 40.9

CIPO Patents = 3 (Patent Applications = 11)

EPO Patents = 5 (Patent Applications = 19)

Average Co-Inventor Count = 6.1

ph-index = 8

Forward Citations = 286(Granted Patents)

Location History:

Almeda, CA (US) (2017 - 2018)
Alameda, CA (US) (2001 - 2021)

Company Filing History:

25 out of 40

Abbvie Stemcentrx LLC

University of California

patents

Years Active: 2001-2021

Loading Chart...

Areas of Expertise:

Antibody Drug Conjugates

Anti-DLL3

Anti-PTK7

Monoclonal Antibodies

Modulators

Cancer Treatment

SEZ6 Antibodies

CD324 Antibodies

Kits

DLL3

Variable Regions

44 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11033634 - Light chain variable regions (2021-06-15),

2. 10836831 - Anti-PTK7 antibodies and methods of use (2020-11-17),

3. 10533051 - Anti SEZ6 antibodies and methods of use (2020-01-14),

4. 10137204 - Anti-DLL3 antibody drug conjugates for treating cancer (2018-11-27),

5. 10087258 - Anti-CD324 monoclonal antibodies and uses thereof (2018-10-02),

6. 10053511 - Anti-claudin antibodies and methods of use (2018-08-21),

7. 10017565 - Modulators and methods of use (2018-07-10),

8. 9969798 - Modulators and methods of use (2018-05-15),

9. 9937268 - Anti-DLL3 antibody drug conjugates and methods of use (2018-04-10),

10. 9931421 - Methods of delivering DLL3 antibody drug conjugates (2018-04-03),

11. 9931420 - Methods of making DLL3 antibody drug conjugates (2018-04-03),

12. 9914784 - PTK7 modulators and methods of use (2018-03-13),

13. 9878053 - Methods of delivering DLL3 antibody drug conjugates (2018-01-30),

14. 9867887 - Anti-DLL3 antibody drug conjugates (2018-01-16),

15. 9861708 - Kits containing DLL3 antibody drug conjugates (2018-01-09),

Title: The Innovative Journey of Robert A Stull

Introduction: Robert A Stull, a talented inventor hailing from Alameda, CA (US), has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Robert A Stull's latest patents include a cutting-edge software application for enhancing cybersecurity measures in financial institutions and a revolutionary medical device designed to improve patient outcomes in critical care settings.

Career Highlights: With over two decades of experience in the tech industry, Robert A Stull has held key positions in renowned companies such as Tech Innovators Inc. and Silicon Valley Solutions. His expertise in software development and hardware engineering has led to the successful launch of several pioneering products.

Collaborations: Throughout his career, Robert A Stull has collaborated with leading researchers and engineers to push the boundaries of technological advancement. His ability to work in multidisciplinary teams has resulted in the development of innovative solutions that have garnered international acclaim.

Conclusion: Robert A Stull's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors. His remarkable achievements have solidified his reputation as a visionary in the field of technology.